Agios Pharmaceuticals
AGIO
#5083
Rank
NZ$2.75 B
Marketcap
NZ$47.23
Share price
-1.93%
Change (1 day)
-36.90%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2025 (TTM): -NZ$0.82 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are NZ$44.79 Million. In 2024 the company made an earning of -NZ$0.74 Billion a decrease over its 2023 earnings that were of -NZ$0.68 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.82 Billion11.97%
2024 -NZ$0.74 Billion8.75%
2023 -NZ$0.68 Billion0.63%
2022 -NZ$0.67 Billion2.81%
2021 -NZ$0.66 Billion10.58%
2020 -NZ$0.59 Billion-18.41%
2019 -NZ$0.73 Billion15.72%
2018 -NZ$0.63 Billion12.99%
2017 -NZ$0.56 Billion59.61%
2016 -NZ$0.35 Billion69.32%
2015 -NZ$0.21 Billion119.28%
2014 -NZ$93.12 Million39.22%
2013 -NZ$66.89 Million69.1%
2012 -NZ$39.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Xencor
XNCR
-NZ$0.24 Billion-70.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.50 B-283.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.38 B-2,592.06%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$1.16 B-242.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$16.03 B-2,060.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Eli Lilly
LLY
NZ$38.70 B-4,831.71%๐Ÿ‡บ๐Ÿ‡ธ USA